ArticleEFSA journal. European Food Safety Authority2025
Risk of infection of dairy cattle in the EU with highly pathogenic avian influenza virus affecting dairy cows in the United States of America (H5N1, Eurasian lineage goose/Guangdong clade 2.3.4.4b. genotype B3.13).
Article in EFSA journal. European Food Safety Authority, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Methods for detecting highly pathogenic avian influenza H5N1 virus in dairy processing environments.Frontiers in microbiology · 2026Article
- Risk of infection of dairy cattle in the EU with highly pathogenic avian influenza virus affecting dairy cows in the United States of America (H5N1, Eurasian lineage goose/Guangdong clade 2.3.4.4b. genotype B3.13).EFSA journal. European Food Safety Authority · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
31 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This opinion assesses the risk of avian influenza H5N1 B3.13 genotype virus infection in EU dairy cattle. Introduction of the virus into EU dairy cattle, poultry or wild birds via trade or migratory birds from the US is assessed as highly unlikely. The potential impact in case of introduction is estimated as high for most Member States. Measures assessed as most effective to prevent introduction of the virus are avoiding importation of cattle and poultry from infected countries, and cleaning and disinfection of milking equipment. Measures assessed as most effective to prevent spread of the virus in the EU are milking hygiene, banning movement of cattle in infected areas, avoiding the exchange of workers, vehicles and equipment, and implementing biosecurity measures before entering farms. Regarding adaptation of current highly pathogenic avian influenza (HPAI) surveillance, a proportional, risk-based preparedness strategy is recommended, including (i) awareness raising to strengthen passive and syndromic surveillance, (ii) targeted investigations of suspicions/outbreaks after confirmed exposure of cattle to HPAI, (iii) using sensitive diagnostics on multiple sample types and (iv) regional active surveillance (bulk milk reverse transcription quantitative polymerase chain reaction (RT-qPCR)) following first detections in cattle. In case the virus is identified in wild birds or poultry, surveillance of dairy farms in the affected area should be considered. The contamination of bulk milk is considered very likely, if EU dairy herds become infected, as cows may not show clear clinical signs and may shed the virus before changes in milk become apparent. If EU bulk milk or colostrum are contaminated with the virus, food-borne exposure of consumers to viable virus would be highest for raw drinking milk, raw colostrum and raw milk cream. To date, however, no confirmed cases of food-borne human infection with H5N1 B3.13 genotype virus have been reported.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.